ArticleCurrent medicinal chemistry2026
Single-Cell Maps Reveal Novel Mechanisms of Ferroptosis and Biomarkers in Diabetic Nephropathy.
Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ferroptosis regulation by SGLT2 inhibitors: mechanisms and clinical benefits in diabetic kidney disease.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveDiabetic nephropathy (DN) is the main cause of renal failure due to its complexity and difficulty in prevention. The purpose of our study is to screen potential biomarkers of DN at the single-cell level and reveal its new molecular pathogenesis by single-cell RNA sequencing (scRNA-seq).
methodsIn this study, scRNA-seq was performed on kidney tissue of control and DN mice. Through multiple analyses of the data, biomarkers in DN that contribute to early diagnosis were screened, and the complex pathogenesis associated with ferroptosis was revealed and verified by experiments at the animal and cellular levels.
resultsThrough customized analysis of scRNA-seq results, we found for the first time increased intercellular communication between mesangial epithelial cells and transitional epithelial cells in the pathological state of DN. In addition, two sets of differential protein interaction analysis networks showed that Eno1, Hspa8, FLT1, Hspa1a, and Gsta2 could be used as predictive biomarkers of DN. Finally, the promoting effects of ferroptosis, heat shock protein and their interactions in the development of DN are discussed. In particular, the regulation of GPX4 by members of the heat shock family, Dnaja1 and Hspa1a, promotes lipid peroxidation (the classic phenotype of ferroptosis). DISCUSSION: We identified disruption of iron homeostasis and activation of the ferroptosis pathway, alongside differential expression of oxidative stress-related genes, including PGAM2. Heat shock proteins (e.g., Hspa1a, Dnaja1) were found to interact with ferroptosis markers (e.g., GPX4), suggesting a chaperone-mediated protective mechanism under diabetic stress. Analogous to the Flory-Huggins solution theory, HSPs may enhance misfolded protein compatibility in the cytosol, reducing aggregation. This study provides insight into HSP-regulated ferroptosis in DN, though further validation is required for clinical translation.
conclusionIn conclusion, we comprehensively analyzed the relevant biomarkers and pathogenesis of DN at single-cell resolution, providing new strategies for therapeutic targets of the disease.
Indexed as
Identifiers
40820457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.